Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience.
Home
About Us
Management Team
Board of Directors
Products in Development
Intermezzo
®
Investors
Press Releases
Events & Presentations
SEC Filings
Corporate Governance
Management Team
Board of Directors
Committee Composition
Stock Information
Historic Stock Lookup
Investment Calculator
Analysts
Shareholder Tools
Shareholder Briefcase
Printed Materials
Email Alerts
Careers
Contact
News & Events
Monday, December 14, 2009
Transcept Pharmaceuticals Receives Notice of Allowance for Second U.S. Patent Application Covering Intermezzo(R)
Monday, November 23, 2009
Transcept Pharmaceuticals Scheduled to Meet With FDA to Discuss Intermezzo(R) Complete Response Letter
Thursday, November 12, 2009
Transcept Pharmaceuticals Reports Third Quarter 2009 Financial Results
Tuesday, November 10, 2009
Transcept Pharmaceuticals to Present at Lazard Capital Markets Healthcare Conference on November 17
Transcept Stock Quote